ArticleGynecologic oncology2017

FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.

Yvette W Jeske et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.